June 15, 2015
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray
The National Institute on Drug Abuse (NIDA) has announced that Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc., has started a rolling…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: NIDA